CIK 0000070487
- Accelerated filer
NRC HEALTH
Sign in to watch- Ticker
- NRC
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 470634000
- Phone
- +1 402-475-2525
- Business address
- 1245 Q STREET, LINCOLN, NE, 68508
- Former names
- NATIONAL RESEARCH CORP
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 13,800 shares (option exercise)
- 4 Open-market sale CEO sold 500,000 shares at $17.45 ($8,725,000)
- 4 Open-market sale CEO sold 14,296 shares at an average $18.48 ($264,202)
- 4 Open-market sale CEO sold 700 shares at $19.00 ($13,300)
- 4 Open-market sale CEO sold 5,482 shares at an average $19.24 ($105,467)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes CEO gave up 14,392 shares (to pay taxes)
- 4 Gift CEO gave 272,722 shares (gift)
- 4 Open-market sale CEO sold 87,010 shares at $16.00 ($1,392,160)
- 4 Open-market sale CEO sold 13,085 shares at $16.00 ($209,360)
- 4 Open-market sale CEO sold 28,009 shares at an average $16.02 ($448,629)
- 4 Open-market sale CEO sold 24,834 shares at an average $16.01 ($397,687)
- 4 Open-market sale CEO sold 18,728 shares at an average $16.04 ($300,353)
- 4 Open-market sale CEO sold 3,675 shares at $16.00 ($58,800)
- 4 Open-market sale CEO sold 10,285 shares at an average $16.02 ($164,729)
- 4 Open-market sale CEO sold 6,473 shares at an average $16.17 ($104,674)
- 4 Exercise or conversion Director acquired 8,300 shares (option exercise)
- 4 Derivatives Options or other derivatives
Page 18 of 40 · 787 filings